Compare with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CLEAN SCIENCE & TECH vs TATVA CHINTAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CLEAN SCIENCE & TECH TATVA CHINTAN PHARMA CLEAN SCIENCE & TECH/
TATVA CHINTAN PHARMA
 
P/E (TTM) x - - - View Chart
P/BV x 48.6 34.8 139.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 CLEAN SCIENCE & TECH   TATVA CHINTAN PHARMA
EQUITY SHARE DATA
    CLEAN SCIENCE & TECH
Mar-21
TATVA CHINTAN PHARMA
Mar-21
CLEAN SCIENCE & TECH/
TATVA CHINTAN PHARMA
5-Yr Chart
Click to enlarge
High RsNANA-   
Low RsNANA-   
Sales per share (Unadj.) Rs48.2149.5 32.3%  
Earnings per share (Unadj.) Rs18.726.0 71.8%  
Cash flow per share (Unadj.) Rs20.329.4 69.1%  
Dividends per share (Unadj.) Rs0.310-  
Avg Dividend yield %NMNM- 
Book value per share (Unadj.) Rs50.882.6 61.5%  
Shares outstanding (eoy) m106.2220.09 528.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x00-   
Avg P/E ratio x00-  
P/CF ratio (eoy) x00-  
Price / Book Value ratio x00-  
Dividend payout %1.70-   
Avg Mkt Cap Rs m00-   
No. of employees `000NANA-   
Total wages/salary Rs m436241 180.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m5,1243,004 170.6%  
Other income Rs m25659 432.2%   
Total revenues Rs m5,3813,063 175.7%   
Gross profit Rs m2,592659 393.1%  
Depreciation Rs m17267 255.6%   
Interest Rs m344 7.3%   
Profit before tax Rs m2,673607 440.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m68984 817.2%   
Profit after tax Rs m1,984523 379.6%  
Gross profit margin %50.622.0 230.4%  
Effective tax rate %25.813.9 185.6%   
Net profit margin %38.717.4 222.5%  
BALANCE SHEET DATA
Current assets Rs m3,9511,843 214.5%   
Current liabilities Rs m1,0201,180 86.4%   
Net working cap to sales %57.222.1 259.4%  
Current ratio x3.91.6 248.2%  
Inventory Days Days1820 50,704.6%  
Debtors Days Days53110 47.9%  
Net fixed assets Rs m2,6481,306 202.8%   
Share capital Rs m106201 52.9%   
"Free" reserves Rs m5,2901,459 362.7%   
Net worth Rs m5,3971,660 325.2%   
Long term debt Rs m3268 1.2%   
Total assets Rs m6,5993,148 209.6%  
Interest coverage x820.914.6 5,604.2%   
Debt to equity ratio x00.2 0.4%  
Sales to assets ratio x0.81.0 81.4%   
Return on assets %30.118.0 167.2%  
Return on equity %36.831.5 116.7%  
Return on capital %49.633.8 146.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m1,928243 793.0%  
From Investments Rs m-1,868-210 889.1%  
From Financial Activity Rs m-59-88 67.0%  
Net Cashflow Rs m1-55 -2.5%  

Share Holding

Indian Promoters % 78.5 79.2 99.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.6 10.9 79.1%  
FIIs % 3.9 3.5 109.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 20.8 103.2%  
Shareholders   244,336 89,438 273.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CLEAN SCIENCE & TECH With:   GODREJ INDUSTRIES  DEEPAK NITRITE  ALKYL AMINES  INDIA GELAT.  DCW.  



Today's Market

5 Reasons Why Sensex Plunged 765 Points Today(Closing)

It was a volatile day for Indian share market today. After opening the day in green, benchmark indices erased gains within the first hour and kept falling as the session progressed.

Related Views on News

Tatva Chintan Makes Blockbuster Debut Doubling Investors Money (Views On News)

Jul 29, 2021

Tatva Chintan Pharma lists at 95% premium over issue price of Rs 1,083.

What Next for Devyani, Zomato, & Tatva Chintan Pharma After Stellar IPO Gains? (Views On News)

Aug 20, 2021

What's the outlook for Devyani, Zomato, and Tatva Chintan Pharma after robust listings?

Ami Organics Stock Makes Impressive Debut on Bourses. Lists at 49% Premium (Views On News)

Sep 14, 2021

Shares of Ami Organics makes a strong debut on the stock exchange. Did you bid for the IPO?

Chemplast Sanmar Makes Flat Debut as IPO Frenzy Fizzles Out (Views On News)

Aug 24, 2021

The grey market had indicated a flat listing for shares of Chemplast Sanmar ahead of its debut.

Understanding Aarti Industries' Demerger (Views On News)

Aug 20, 2021

Will the pharma unit's demerger unlock value for shareholders?

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CLEAN SCIENCE & TECH SHARE PRICE


Dec 3, 2021 (Close)

TRACK CLEAN SCIENCE & TECH

  • Track your investment in CLEAN SCIENCE & TECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CLEAN SCIENCE & TECH

CLEAN SCIENCE & TECH 5-YR ANALYSIS

COMPARE CLEAN SCIENCE & TECH WITH

MARKET STATS